No insider purchase over the last 90 days. The latest, by Warbington Timothy, was filed 29 Jun 2023.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 43 declarations
The heaviest trades at Creative Medical Technology Holdings, Inc. cluster at the end of 2016: on December 31, 2016, Creative Medical Health Inc., a 10% owner, and Timothy Warbington, president and CEO, each reported a sale of EUR 277,591. Timothy Warbington also sold EUR 32,756 on December 18, 2016. In all, 19 sales (18 with an amount) weigh EUR 638,216, median EUR 835, against 8 purchases for EUR 160,515 (median EUR 5,217): 30% purchases.
The largest purchase, EUR 93,781 on December 2, 2016, is by Timothy Herbst, a 10% owner. On September 30, 2016, Creative Medical Health Inc. and Timothy Warbington each bought EUR 26,739. Timothy Warbington has 21 filings, 5 purchases and 8 sales; Michael H. Finger, a director, 3; Steven L. White, president, one sale.
Five insiders filed 43 times, with a peak of 17 in 2017. The record holds 16 filings that are neither purchases nor sales. Filings are published a median of 2 days after the trade. The Nasdaq-listed company has a market capitalisation of USD 5,730,103, and insiders hold 15.7%. There is no filing over the last twelve months.